Exaggerated inflammation and monocytosis associate with diastolic dysfunction in heart failure with preserved ejection fraction: Evidence of M2 macrophage activation in disease pathogenesis

Journal of Cardiac Failure

Volumn 21, Issue 2, 2015, Pages 167-177

  Glezeva, Nadezhda ^a   Voon, Victor ^b   Watson, Chris ^a   Horgan, Stephen ^a,b   McDonald, Kenneth ^a,b   Ledwidge, Mark ^b   Baugh, John ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

heart failure with preserved ejection fraction; hypertension; inflammation; Monocytes

Indexed keywords

AUTACOID;

AGED; BLOOD; FEMALE; HEART FAILURE, DIASTOLIC; HEART STROKE VOLUME; HUMAN; INFLAMMATION; MACROPHAGE ACTIVATION; MALE; METABOLISM; MIDDLE AGED; MONOCYTE; MONONUCLEAR CELL; PHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; HEART FAILURE, DIASTOLIC; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LEUKOCYTES, MONONUCLEAR; MACROPHAGE ACTIVATION; MALE; MIDDLE AGED; MONOCYTES; STROKE VOLUME;

EID: 84921846409     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2014.11.004     Document Type: Article

References (54)

1. B.A. Borlaug, and W.J. Paulus Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment Eur Heart J 32 2011 670 679
2. W.J. Paulus, and J.J. van Ballegoij Treatment of heart failure with normal ejection fraction: an inconvenient truth! J Am Coll Cardiol 55 2010 526 537
3. S.H. Wan, M.W. Vogel, and H.H. Chen Pre-clinical diastolic dysfunction J Am Coll Cardiol 63 2014 407 416
4. J.J. McMurray, P.E. Carson, M. Komajda, R. McKelvie, M.R. Zile, and A. Ptaszynska Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial Eur J Heart Fail 10 2008 149 156
5. D. Westermann, D. Lindner, M. Kasner, C. Zietsch, K. Savvatis, and F. Escher Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction Circ Heart Fail 4 2011 44 52
6. W.J. Paulus, and C. Tschope A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation J Am Coll Cardiol 62 2013 263 271
7. J.M. van Gils, J.J. Zwaginga, and P.L. Hordijk Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases J Leukoc Biol 85 2009 195 204
8. K. Fujiu, and R. Nagai Contributions of cardiomyocyte-cardiac fibroblast-immune cell interactions in heart failure development Basic Res Cardiol 108 2013 357
9. H. Kai, F. Kuwahara, K. Tokuda, and T. Imaizumi Diastolic dysfunction in hypertensive hearts: roles of perivascular inflammation and reactive myocardial fibrosis Hypertens Res 28 2005 483 490
10. Y. Xia, K. Lee, N. Li, D. Corbett, L. Mendoza, and N.G. Frangogiannis Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload Histochem Cell Biol 131 2009 471 481
11. H. Tsujioka, T. Imanishi, H. Ikejima, A. Kuroi, S. Takarada, and T. Tanimoto Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction J Am Coll Cardiol 54 2009 130 138
12. B. Pamukcu, G.Y. Lip, A. Devitt, H. Griffiths, and E. Shantsila The role of monocytes in atherosclerotic coronary artery disease Ann Med 42 2010 394 403
13. M. Fernandez-Velasco, S. Gonzalez-Ramos, and L. Bosca Involvement of monocytes/macrophages as key factors in the development and progression of cardiovascular diseases Biochem J 458 2014 187 193
14. J.M. Cahill, E. Ryan, B. Travers, M. Ryder, M. Ledwidge, and K. McDonald Progression of preserved systolic function heart failure to systolic dysfunction - a natural history study Int J Cardiol 106 2006 95 102
15. S. Apostolakis, G.Y. Lip, and E. Shantsila Monocytes in heart failure: relationship to a deteriorating immune overreaction or a desperate attempt for tissue repair? Cardiovasc Res 85 2010 649 660
16. K. Fujiu, J. Wang, and R. Nagai Cardioprotective function of cardiac macrophages Cardiovasc Res 102 2014 232 239
17. E. Shantsila, B. Wrigley, L. Tapp, S. Apostolakis, S. Montoro-Garcia, and M.T. Drayson Immunophenotypic characterization of human monocyte subsets: possible implications for cardiovascular disease pathophysiology J Thromb Haemost 9 2011 1056 1066
18. B.J. Wrigley, G.Y. Lip, and E. Shantsila The role of monocytes and inflammation in the pathophysiology of heart failure Eur J Heart Fail 13 2011 1161 1171
19. E. Shantsila, and G.Y. Lip Monocyte diversity in myocardial infarction J Am Coll Cardiol 54 2009 139 142
20. L.D. Tapp, E. Shantsila, B.J. Wrigley, B. Pamukcu, and G.Y. Lip The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction J Thromb Haemost 10 2012 1231 1241
21. A. Schlitt, G.H. Heine, S. Blankenberg, C. Espinola-Klein, J.F. Dopheide, and C. Bickel CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels Thromb Haemost 92 2004 419 424
22. C. Barisione, S. Garibaldi, G. Ghigliotti, P. Fabbi, P. Altieri, and M.C. Casale CD14CD16 monocyte subset levels in heart failure patients Dis Markers 28 2010 115 124
23. O. Amir, I. Spivak, I. Lavi, and M.A. Rahat Changes in the monocytic subsets CD14(dim)CD16(+) and CD14(++)CD16(-) in chronic systolic heart failure patients Mediators Inflamm 2012 2012 616384
24. B.J. Wrigley, E. Shantsila, L.D. Tapp, and G.Y. Lip CD14++CD16+ monocytes in patients with acute ischaemic heart failure Eur J Clin Invest 43 2013 121 130
25. T. Bagnost, L. Ma, R.F. da Silva, R. Rezakhaniha, C. Houdayer, and N. Stergiopulos Cardiovascular effects of arginase inhibition in spontaneously hypertensive rats with fully developed hypertension Cardiovasc Res 87 2010 569 577
26. H2/M2 responses in models of inflammation lacking cell death stimulates maturation of monocyte precursors to fibroblasts Front Immunol 4 2013 287
27. D. Phelan, C. Watson, R. Martos, P. Collier, A. Patle, and S. Donnelly Modest elevation in BNP in asymptomatic hypertensive patients reflects sub-clinical cardiac remodeling, inflammation and extracellular matrix changes PLoS One 7 2012 e49259
28. T.J. Wang, M.G. Larson, D. Levy, E.J. Benjamin, E.P. Leip, and T. Omland Plasma natriuretic peptide levels and the risk of cardiovascular events and death N Engl J Med 350 2004 655 663
29. S. Adamopoulos, J.T. Parissis, and D.T. Kremastinos A glossary of circulating cytokines in chronic heart failure Eur J Heart Fail 3 2001 517 526
30. P. Collier, C.J. Watson, V. Voon, D. Phelan, A. Jan, and G. Mak Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure? Eur J Heart Fail 13 2011 1087 1095
31. A. Kalogeropoulos, V. Georgiopoulou, B.M. Psaty, N. Rodondi, A.L. Smith, and D.G. Harrison Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study J Am Coll Cardiol 55 2010 2129 2137
32. R. Kell, A. Haunstetter, T.J. Dengler, C. Zugck, W. Kubler, and M. Haass Do cytokines enable risk stratification to be improved in NYHA functional class III patients? Comparison with other potential predictors of prognosis Eur Heart J 23 2002 70 78
33. M.R. Fernando, J.L. Reyes, J. Iannuzzi, G. Leung, and D.M. McKay The pro-inflammatory cytokine, interleukin-6, enhances the polarization of alternatively activated macrophages PLoS One 9 2014 e94188
34. H.J. Moller Soluble CD163 Scand J Clin Lab Invest 72 2012 1 13
35. D.V. Pechkovsky, A. Prasse, F. Kollert, K.M. Engel, J. Dentler, and W. Luttmann Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction Clin Immunol 137 2010 89 101
36. S.P. Atamas, I.G. Luzina, J. Choi, N. Tsymbalyuk, N.H. Carbonetti, and I.S. Singh Pulmonary and activation-regulated chemokine stimulates collagen production in lung fibroblasts Am J Respir Cell Mol Biol 29 2003 743 749
37. A.O. Kraaijeveld, S.C. de Jager, W.J. de Jager, B.J. Prakken, S.R. McColl, and I. Haspels CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms Circulation 116 2007 1931 1941
38. J. De Sutter, S. Struyf, N.R. van de Veire, J. Philippe, M. de Buyzere, and J. van Damme Cardiovascular determinants and prognostic significance of CC chemokine ligand-18 (CCL18/PARC) in patients with stable coronary artery disease J Mol Cell Cardiol 49 2010 894 896
39. Y. Maekawa, T. Anzai, T. Yoshikawa, Y. Asakura, T. Takahashi, and S. Ishikawa Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction:a possible role for left ventricular remodeling J Am Coll Cardiol 39 2002 241 246
40. G. Engstrom, O. Melander, and B. Hedblad Leukocyte count and incidence of hospitalizations due to heart failure Circ Heart Fail 2 2009 217 222
41. P. Akila, V. Prashant, M.N. Suma, S.N. Prashant, and T.R. Chaitra CD163 and its expanding functional repertoire Clin Chim Acta 413 2012 669 674
42. L.M. Cordeiro, S.M. de Oliveira, D.F. Buchi, and M. Iacomini Galactofuranose-rich heteropolysaccharide from Trebouxia sp., photobiont of the lichen Ramalina gracilis and its effect on macrophage activation Int J Biol Macromol 42 2008 436 440
43. P. Pelegrin, and A. Surprenant Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1beta release through pyrophosphates EMBO J 28 2009 2114 2127
44. A. Mantovani, A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati The chemokine system in diverse forms of macrophage activation and polarization Trends Immunol 25 2004 677 686
45. S. Tamaki, T. Mano, Y. Sakata, T. Ohtani, Y. Takeda, and D. Kamimura Interleukin-16 promotes cardiac fibrosis and myocardial stiffening in heart failure with preserved ejection fraction PLoS One 8 2013 e68893
46. S. Ather, W. Chan, B. Bozkurt, D. Aguilar, K. Ramasubbu, and A.A. Zachariah Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction J Am Coll Cardiol 59 2012 998 1005
47. A. Taube, R. Schlich, H. Sell, K. Eckardt, and J. Eckel Inflammation and metabolic dysfunction: links to cardiovascular diseases Am J Physiol Heart Circ Physiol 302 2012 H2148 H2165
48. S. Jelic, D.J. Lederer, T. Adams, M. Padeletti, P.C. Colombo, and P.H. Factor Vascular inflammation in obesity and sleep apnea Circulation 121 2010 1014 1021
49. I.C. Macdougall, B. Canaud, A.L. de Francisco, G. Filippatos, P. Ponikowski, and D. Silverberg Beyond the cardiorenal anaemia syndrome: recognizing the role of iron deficiency Eur J Heart Fail 14 2012 882 886
50. K.S. Rogacev, S. Seiler, A.M. Zawada, B. Reichart, E. Herath, and D. Roth CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease Eur Heart J 32 2011 84 92
51. M. Spencer, A. Yao-Borengasser, R. Unal, N. Rasouli, C.M. Gurley, and B. Zhu Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation Am J Physiol Endocrinol Metab 299 2010 E1016 E1027
52. G. Cairo, S. Recalcati, A. Mantovani, and M. Locati Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype Trends Immunol 32 2011 241 247
53. J. Haase, U. Weyer, K. Immig, N. Kloting, M. Bluher, and J. Eilers Local proliferation of macrophages in adipose tissue during obesity-induced inflammation Diabetologia 57 2014 562 571
54. L.H. Lund, E. Donal, E. Oger, C. Hage, H. Persson, and I. Haugen-Lofman Association between cardiovascular vs. non-cardiovascular co-morbidities and outcomes in heart failure with preserved ejection fraction Eur J Heart Fail 16 2014 992 1001